News
Glucagon-like peptide 1 receptor agonists may offer neuroprotective and survival benefits beyond blood sugar control.
GLP-1 RAs used by adults with type 2 diabetes and obesity is linked to lower risk for dementia, stroke, and mortality vs ...
“Weight loss quality is a new concept….The discussion no longer revolves around the lack of adequate efficacy but rather ...
British Columbia's Ministry of Health is limiting the sales of two more diabetes drugs to curb their off-label use for weight ...
8h
Zacks.com on MSNCan Wegovy & Ozempic Drive Another Strong Quarter for Novo Nordisk?Novo Nordisk NVO generates most of its revenues from the sales of its blockbuster GLP-1 injections, Ozempic for type II ...
The Canadian Press on MSN23h
B.C. limits sales of two more diabetes drugs used for weight lossBritish Columbia's Health Ministry is limiting the sales of two more diabetes drugs to curb their off-label use for weight ...
23h
The Vancouver Sun on MSNB.C. restricts sales of two more diabetes drugs amid weight-loss demandThe B.C. government is restricting the sales of two more diabetes drugs to people outside Canada amid rising demand for the ...
KATIE Price has revealed her son Harvey now weighs 30st, as she gave fans an update on him taking weight loss jabs. The ...
A MOTHER has managed to shift over three stone thanks to Mounjaro, but has revealed the five things she wishes she had known ...
14h
Onlymyhealth on MSNDon't Just Take Medication, Take Control: US Hospitals Recommend The MEAL Plan For Weight Loss SuccessAs medications like 'Wegovy' and 'Ozempic' (GLP‑1 receptor agonists) become more common in weight‑loss strategies, US ...
New weight management drugs could be used to create a global metabolic health revolution and improve longevity, if investment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results